Nasdaq

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use

Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® ...
Nasdaq

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
Pharmabiz

LumiraDx SARS CoV-2 antigen test receives Swiss approval to detect COVID-19

LumiraDx, a next-generation point-of-care diagnostics company, announced that it has received Swiss approval from the Federal Office of Public Health (BAG) <165 for the LumiraDx SARS CoV-2 antigen ...
Drug Store News

BDSC Company to distribute CorDx Flu A/B & COVID-19 At-Home Rapid Test

BDSC Company to distribute CorDx Flu A/B & COVID-19 At-Home Rapid Test The 3-in-1 self-test is intended for the qualitative detection and differentiation of nucleocapsid protein antigens from ...
The New England Journal of Medicine

False Positive Covid-19 Rapid Antigen Tests

The potential for IgM cross-reactivity with rheumatoid factor–positive serum samples was observed in blood tests used to detect IgM SARS-CoV-2 by means of gold immunochromatographic and enzyme-linked ...
News Medical

Early viral activity plays critical role in long COVID, study suggests

In a recent study published in Nature Communications, researchers explored the roles of acute-phase virological dynamics and host immunological responses in post-acute infection sequelae of ...